Onco-haematology Vigilance Card
NCT04931329 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-11-10
Summary
The objective of this study is to show the interest of setting up a drug vigilance card in Oncology in order to reinforce patient safety, develop compliance and avoid drug interactions when the patient consults town professionals or other specialists.
Conditions
- Medical Oncology
- Hematology
- Molecular Targeted Therapies
Sponsors & Collaborators
-
University Hospital, Limoges
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-02
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- France
Study Locations
More Related Trials
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors
NCT03257969 ·Status: RECRUITING ·Phase: NA
-
PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy
NCT04128865 ·Status: UNKNOWN
-
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
NCT00751205 ·Status: COMPLETED ·Phase: PHASE2
-
The Validation of a Novel Adherence Method for Oral Oncolytics
NCT03561272 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma
NCT06031194 ·Status: COMPLETED
-
Pharmacogenomic Testing to Personalize Supportive Oncology
NCT04500301 ·Status: COMPLETED ·Phase: NA
-
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT02828462 ·Status: UNKNOWN
-
Tolerance of Anti-Cancer Therapy in the Elderly
NCT05251922 ·Status: UNKNOWN
-
Treatment of Breakthrough Cancer Pain According to European Guidelines
NCT04468490 ·Status: TERMINATED
-
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
NCT01053104 ·Status: COMPLETED
-
Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety
NCT06483685 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study to Assess Adherence Oral Anticancer Therapies
NCT03195972 ·Status: COMPLETED
-
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
NCT04042298 ·Status: COMPLETED
-
Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
NCT06317714 ·Status: RECRUITING
-
Adherence to Oral Anticancer Treatment Using Electronic Monitoring System
NCT01058044 ·Status: COMPLETED ·Phase: NA
-
Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation
NCT04142567 ·Status: COMPLETED
-
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
NCT00005590 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
NCT00113438 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
NCT07054528 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
NCT04091711 ·Status: SUSPENDED ·Phase: NA
-
Optimization of the Targeted Anticancer Therapies
NCT04484064 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors
NCT00570284 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Side Effects of Mitotane
NCT00568139 ·Status: ACTIVE_NOT_RECRUITING
-
Optimizing the Management of Patients With Oral Therapy
NCT03623490 ·Status: TERMINATED ·Phase: NA